Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liwei Wu

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 12, 2017
The natural product fucoidan ameliorates hepatic ischemia-reperfusion injury in miceJingjing Li, QingHui Zhang, Sainan Li, et al.
Journal of Cellular and Molecular Medicine|April 16, 2022
Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c-myc/hexokinase 2 pathwayQiang Yu, Weiqi Dai, Jie Ji, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 19, 2019
PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinomaJiao Feng, Liwei Wu, Jie Ji, et al.
Mediators of Inflammation|January 10, 2019
The Protective Effects of Levo-Tetrahydropalmatine on ConA-Induced Liver Injury Are via TRAF6/JNK SignalingQiang Yu, Tong Liu, Sainan Li, et al.
The Journal of Clinical Investigation|May 1, 2024
Cirbp suppression compromises DHODH-mediated ferroptosis defense and attenuates hypothermic cardioprotection in an aged donor transplantation modelYifan Zhu, Chenyu Jiang, Jian He, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 5, 2023
Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosisYan Li, Wenjuan Yang, Yuanyuan Zheng, et al.
British Journal of Pharmacology|May 24, 2020
Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non-alcoholic fatty liver disease by up-regulating the FGF21/PGC-1α pathwayLiwei Wu, Wenhui Mo, Jiao Feng, et al.
Oncotarget|May 13, 2017
Methyl jasmonate leads to necrosis and apoptosis in hepatocellular carcinoma cells via inhibition of glycolysis and represses tumor growth in miceJingjing Li, Kan Chen, Fan Wang, et al.
Mediators of Inflammation|December 15, 2022
Cordycepin Protects against Hepatic Ischemia/Reperfusion Injury via Inhibiting MAPK/NF-<i>κ</i>B PathwayJiameng Ding, WenjuanYang, Yuhui Jiang, et al.
PPAR Research|August 15, 2022
Luteolin Pretreatment Attenuates Hepatic Ischemia-Reperfusion Injury in Mice by Inhibiting Inflammation, Autophagy, and Apoptosis via the ERK/PPAR<i>α</i> PathwayYuhui Jiang, Wenjuan Yang, Jiameng Ding, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 12, 2017
The natural product fucoidan ameliorates hepatic ischemia-reperfusion injury in miceJingjing Li, QingHui Zhang, Sainan Li, et al.
Journal of Cellular and Molecular Medicine|April 16, 2022
Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c-myc/hexokinase 2 pathwayQiang Yu, Weiqi Dai, Jie Ji, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 19, 2019
PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinomaJiao Feng, Liwei Wu, Jie Ji, et al.
Mediators of Inflammation|January 10, 2019
The Protective Effects of Levo-Tetrahydropalmatine on ConA-Induced Liver Injury Are via TRAF6/JNK SignalingQiang Yu, Tong Liu, Sainan Li, et al.
The Journal of Clinical Investigation|May 1, 2024
Cirbp suppression compromises DHODH-mediated ferroptosis defense and attenuates hypothermic cardioprotection in an aged donor transplantation modelYifan Zhu, Chenyu Jiang, Jian He, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 5, 2023
Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosisYan Li, Wenjuan Yang, Yuanyuan Zheng, et al.
British Journal of Pharmacology|May 24, 2020
Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non-alcoholic fatty liver disease by up-regulating the FGF21/PGC-1α pathwayLiwei Wu, Wenhui Mo, Jiao Feng, et al.
Oncotarget|May 13, 2017
Methyl jasmonate leads to necrosis and apoptosis in hepatocellular carcinoma cells via inhibition of glycolysis and represses tumor growth in miceJingjing Li, Kan Chen, Fan Wang, et al.
Mediators of Inflammation|December 15, 2022
Cordycepin Protects against Hepatic Ischemia/Reperfusion Injury via Inhibiting MAPK/NF-<i>κ</i>B PathwayJiameng Ding, WenjuanYang, Yuhui Jiang, et al.
PPAR Research|August 15, 2022
Luteolin Pretreatment Attenuates Hepatic Ischemia-Reperfusion Injury in Mice by Inhibiting Inflammation, Autophagy, and Apoptosis via the ERK/PPAR<i>α</i> PathwayYuhui Jiang, Wenjuan Yang, Jiameng Ding, et al.
Pageof 12